TY - JOUR
T1 - Near-infrared spectroscopy for the in-line characterization of powder voiding part II
T2 - Quantification of enhanced flow properties of surface modified active pharmaceutical ingredients
AU - Beach, Lauren
AU - Ropero, Jorge
AU - Mujumdar, Ajit
AU - Alcalà, Manel
AU - Romañach, Rodolfo J.
AU - Davé, Rajesh N.
N1 - Funding Information:
Acknowledgments Authors acknowledge the National Science Foundation (ERC research grant: EEC-0540855) for providing support for this collaborative research. Thanks are also due to Raizza Rentas and Hendri Chauca for their contributions to the experimental work which they did during their summer REU (Research Experience for Undergraduates) program at NJIT.
PY - 2010
Y1 - 2010
N2 - In this work, dry-particle coating was used to modify the surface properties of active pharmaceutical ingredients (APIs) having extremely poor flow properties. Near-infrared (NIR) spectroscopy was utilized as a novel approach to characterize the improved flow behavior of APIs and their blends. Acetaminophen and ibuprofen were coated with nano-sized silica at two different coating levels (0.5% and 1% w/w of the API) in dry-particle coating devices viz. magnetically assisted impaction coater (MAIC) and Hybridizer. Surface modified (dry coated) APIs were then blended with excipient (spray dried lactose monohydrate) in a V-blender. As a baseline comparison to dry coating, the silica addition was also accomplished by two commonly used industry methods, i.e., passing a portion of API with silica through a sieve (sieve blending method) or blending a portion of API powder with silica in a V-blender (preblending method). Flow results showed that dry particle coated acetaminophen as well as ibuprofen blends performed significantly better than uncoated API blends at higher API concentrations. In addition, examination of the flow intensity from NIR spectra (inverse signal to noise ratio of spectra) and its standard deviation revealed that dry particle coated blends showed better uniformity of flow as compared to the other methods. Angle of repose measurements corroborated these results, showing that the majority of the blends prepared from coated APIs stayed in either passable or fair category.
AB - In this work, dry-particle coating was used to modify the surface properties of active pharmaceutical ingredients (APIs) having extremely poor flow properties. Near-infrared (NIR) spectroscopy was utilized as a novel approach to characterize the improved flow behavior of APIs and their blends. Acetaminophen and ibuprofen were coated with nano-sized silica at two different coating levels (0.5% and 1% w/w of the API) in dry-particle coating devices viz. magnetically assisted impaction coater (MAIC) and Hybridizer. Surface modified (dry coated) APIs were then blended with excipient (spray dried lactose monohydrate) in a V-blender. As a baseline comparison to dry coating, the silica addition was also accomplished by two commonly used industry methods, i.e., passing a portion of API with silica through a sieve (sieve blending method) or blending a portion of API powder with silica in a V-blender (preblending method). Flow results showed that dry particle coated acetaminophen as well as ibuprofen blends performed significantly better than uncoated API blends at higher API concentrations. In addition, examination of the flow intensity from NIR spectra (inverse signal to noise ratio of spectra) and its standard deviation revealed that dry particle coated blends showed better uniformity of flow as compared to the other methods. Angle of repose measurements corroborated these results, showing that the majority of the blends prepared from coated APIs stayed in either passable or fair category.
KW - Angle of repose
KW - Dry-particle coating
KW - Flow additives
KW - Flow improvement of APIs
KW - Flow uniformity
KW - Nano silica
KW - Near-infrared spectroscopy
KW - Surface modification
UR - http://www.scopus.com/inward/record.url?scp=75149159180&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=75149159180&partnerID=8YFLogxK
U2 - 10.1007/s12247-010-9075-1
DO - 10.1007/s12247-010-9075-1
M3 - Article
AN - SCOPUS:75149159180
SN - 1872-5120
VL - 5
SP - 1
EP - 13
JO - Journal of Pharmaceutical Innovation
JF - Journal of Pharmaceutical Innovation
IS - 1-2
ER -